that combines patient care, health promotion and beauty by providing chelation programs for detoxifying blood vessels, weight loss programs, and colon therapy services. October The Company was ranked
8,016 5,337 2,679 50% Total Expenses (7,221) (4,956) (156) (126) (7,377) (5,082) 2,295 45% Share of Profit (Loss) 2,417 2,037 12 4 2,429 2,041 388 19% Profit (Loss) before FX, deferred income tax
cannot undertake any responsibility for its accuracy, nor be held liable for any loss or damages arising from or related to its use. Notification of The Office of the Securities and Exchange Commission No
, Thailand cannot undertake any responsibility for its accuracy, nor be held liable for any loss or damages arising from or related to its use. Notification of The Office of the Securities and Exchange
80.81% of CCPH shares from the received of 8,956,377 CCPH shares at post-transaction. As a result, the Company shall record profit and loss of CCPH’s using equity method to reflecting its shareholding of
approved by the Board of Directors. From the nine-month operations, the Company had a net loss of 96.03 million baht in which there is a loss attributable for the equity holders of the Company of 102.81
statements for the third quarter ended 30th September 2018 which was duly approved by the Board of Directors. From the nine-month operations, the Company had a net loss of 47.58 million baht in which there is
) (11.18) Net Profit (Loss) (43.62) (6.22) 37.40 601.29 Earnings per share (Baht per share) (0.008) (0.001) 0.007 700.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of
108,803,656 133,755,071 (24,951,415) (18.66) Net Profit (Loss) (72,320,514) (72,280,526) (39,988) (0.06) Earnings per share (Baht per share) (0.015) (0.016) 0.001 6.25 Net Profit (Loss) The Company and
108,803,656 133,755,071 (24,951,415) (18.66) Net Profit (Loss) (72,320,514) (72,280,526) (39,988) (0.06) Earnings per share (Baht per share) (0.015) (0.016) 0.001 6.25 Net Profit (Loss) The Company and